FORMULATION OPTIMIZATION AND EVALUATION OF MOUTH DISSOLVING FILM OF RAMOSETRON HYDROCHLORIDE

  • ZANKAHANA PATEL Department of Pharmaceutics, Sardar Patel College of Pharmacy, Bakrol, 388315, Gujarat, India
  • RAHIL BHURA Department of Pharmaceutics, Sardar Patel College of Pharmacy, Bakrol, 388315, Gujarat, India
  • SAMIR SHAH Department of Pharmaceutics, Sardar Patel College of Pharmacy, Bakrol, 388315, Gujarat, India

Abstract

Objective: Ramosetron Hydrochloride is found to be more potent and having a longer duration of action with the least side effects, but the major drawback is it undergoes hepatic first-pass metabolism so our aim is to prepare mouth dissolving film (MDF) of Ramosetron hydrochloride for rapid relief in emesis.


Methods: The mouth dissolving films of Ramosetron Hydrochloride were prepared by using the solvent casting method. Films were formulated using HPMC E5 (Hydroxy Propyl Methyl Cellulose) as a film-forming agent, PEG400 (Polyethylene glycol) as a plasticizer and Aspartame as the sweetening agent. A 32 full factorial design was applied considering the concentration of HPMC E5 (X1) and concentration of PEG400 (X2) as independent variables and % cumulative drug release (Y1) (CDR), disintegration time (Y2) (DT) and tensile strength (Y3) (TS) as dependent variables. The prepared films were evaluated for thickness, folding endurance, tensile strength, disintegration time, drug content uniformity and taste masking by E-tongue. The results indicated that factors X1 and X2 were found to be having a positive effect on DT and TS and negative effects on CDR.


Results: The optimized formulation was found to be the best with 94.00±0.85% in vitro drug release, 33.22±0.75 sec DT and 1.359±0.005 g/mm2 tensile strength. Concentration of aspartame was optimized with E-tongue taking into consideration increased electric potential with decreasing bitterness.


Conclusion: Thus, a rapidly dissolving oral film of Ramosetron Hydrochloride with successful taste masking and immediate in vitro drug release was prepared using a solvent casting technique.

Keywords: Ramosetron Hydrochloride, Rapidly dissolving oral film, E-tongue, HPMC E5

References

1. Joshua JM, Hari R, Jyothish FK, Surendran SA. Fast dissolving oral thin films: an effective dosage form for quick releases. Int J Pharm Sci Rev Res 2016;38:282–9.
2. Gupta P, Bisht A, Rao NGR. Fast dissolving oral films: a comprehensive review. World J Pharm Res 2019;5:116–27.
3. Zarana M, Darshil B, Dilip. Development and validation of stability indicating HPLC method for estimation of ramosetron Hcl. World J Pharm Res 2014;3:4527–35.
4. Mujoo S, Ali Z, Jehangir M, Iqbal A, Qayoom N, Lone A. A comparative evaluation of ramosetron with ondansetron for the prevention of postoperative nausea and vomiting in patients undergoing urological procedures. Anesth Essays Res 2017;11:78.
5. Sarkar S, Bhattacharyya N, Palakurthi VK. Taste recognizer by multi-sensor electronic tongue: a case study with tea quality classification. In: Proceedings-2nd International Conference on Emerging Applications of Information Technology, EAIT; 2011. p. 138–41.
6. Sarkar S. Basic and mixed taste analysis using voltammetric electronic tongue. Int Conf VLSI, Commun Instrum (Icvci); 2011. p. 27–33.
7. Dangre PV, Phad RD, Surana SJ, Chalikwar SS. Quality by design (QbD) assisted fabrication of fast dissolving buccal film for clonidine hydrochloride: exploring the quality attributes. Adv Polym Technol 2019:1-13. https://doi.org/10.1155/2019/ 3682402.
8. Roshan B, Ravindranath S. Journal of drug delivery and therapeutics (jddt). J Drug Delivery Ther 2019;9:661–8.
9. Lakshmi PK, Malavika P, Vidya K. Formulation and evaluation of oral films of atomoxetine hydrochloride. Int Res J Pharm 2018;9:105–9.
10. Reddy U, Reddy S, Katta M, Thyagaraju K. A detailed review on fast dissolving oral films. Indo Am J Pharm Res 2018;8:1351–26.
Statistics
58 Views | 72 Downloads
Citatons
How to Cite
PATEL, Z., R. BHURA, and S. SHAH. “FORMULATION OPTIMIZATION AND EVALUATION OF MOUTH DISSOLVING FILM OF RAMOSETRON HYDROCHLORIDE”. International Journal of Current Pharmaceutical Research, Vol. 12, no. 3, May 2020, pp. 99-106, doi:10.22159/ijcpr.2020v12i3.38315.
Section
Original Article(s)